Head circumference in infants with non-opiate-induced neonatal abstinence syndrome
Head circumference in infants with non-opiate-induced neonatal abstinence syndrome
复制标题
非阿片类药物引起的新生儿戒断综合征婴儿的头围
DOI:
10.1017/s1092852920001522
复制
发表时间:
2020
期刊:
影响因子:
--
通讯作者:
Tsukahara H
中科院分区:
文献类型:
--
作者:
Morimoto D;Washio Y;Hatayama K;Okamura T;Watanabe H;Yoshimoto J;Tsukahara H
BackgroundNo relationship has been reported between nonopiate neonatal abstinence syndrome (NAS) and anthropometric indices, including head circumference (HC). The purpose of this study was to determine the relationship between maternal nonopioid drug use and HC at birth in neonates with NAS.MethodsThis retrospective observational study included neonates born between January 1, 2010 and March 31, 2019, whose mothers had been taking antipsychotic, antidepressant, sedative, or anticonvulsant medications. The outcome measures were HCs of NAS infants and controls.ResultsOf 159 infants, 33 (21%) were diagnosed with NAS. There was no maternal opioid use among mothers during pregnancy. The HCs in the NAS group were significantly smaller than those in the control group. The median z-scores for HC at birth were −0.20 and 0.29 in the NAS group and the control group, respectively (P = .011). The median HCs at birth were 33.0 and 33.5 cm in the NAS group and the control group, respectively. Multivariate analysis revealed that maternal antipsychotic drug use and selective serotonin reuptake inhibitors were independently associated with NAS (P < .001 and P = .004, respectively). Notably, benzodiazepine use and smoking were not independent risk factors.ConclusionsThe results suggest an association between maternal antipsychotic drug use and NAS, which was further associated with decreased HC. Careful monitoring of maternal drug use should be considered to improve fetal outcomes.